WANBURY
|
The Current P/B Ratio of WANBURY is -15.06.
Share Price | ₹158.6 | Apr 25,2024 |
Market Cap | ₹518.6 Cr | |
Book Value | ₹-34.4 Cr | Mar2023 - Consolidated Results |
Price/Book | -15.06x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of WANBURY
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹518.6 Cr] as on Apr 25,2024
(/) Book Value [ ₹-34.4 Cr] based on Mar2023 - Consolidated Results
(=) P/B Ratio [ -15.06x ]
Thus, for WANBURY , the investors are currently willing to pay '-15.06 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of WANBURY !
The chart below summarizes the trend in P/B Ratio of WANBURY over the last five years.
Historical PB (Price/Book ) ratio chart of WANBURY
PB Ratio Performance Analysis for WANBURY
- WANBURY 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged -3.34x.
- WANBURY 's operated at median p/b ratio of -1.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/b ratio peaked in Mar2019 at -0.25x.
- WANBURY 's p/b ratio hit its five-year low in Mar2022 of -11.25x.
How does WANBURY 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
WANBURY | -34.45 | -15.06 | 518.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 55,995.40 | 6.52 | 364,831.0 |
CIPLA LTD | 23,346.00 | 4.86 | 113,471.0 |
DR REDDYS LABORATORIES LTD | 23,140.40 | 4.48 | 103,713.0 |
ZYDUS LIFESCIENCES LTD | 17,515.80 | 5.46 | 95,687.8 |
DIVIS LABORATORIES LTD | 12,767.10 | 7.99 | 101,960.0 |
MANKIND PHARMA LTD | 7,435.16 | 12.92 | 96,093.1 |
TORRENT PHARMACEUTICALS LTD | 6,198.07 | 14.70 | 91,124.7 |
LUPIN LTD | 12,315.60 | 5.90 | 72,687.6 |
AUROBINDO PHARMA LTD | 26,839.80 | 2.41 | 64,661.3 |
ABBOTT INDIA LTD | 3,146.02 | 17.33 | 54,533.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs WANBURY 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | -15.06x |
Max industry PB | 17.33x |
Median industry PB | 5.90x |
Average industry PB | 6.14x |
You may also like the below Video Courses